NCT05953896

Brief Summary

This research aims to investigate the effectiveness of non invasive application Hyaluronic acid gel injection versus minimally invasive surgical approach using multilayer L-PRF both clinically and radiographically as a suitable treatment modality for interdental papillary deficiency.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 17, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 20, 2023

Completed
Last Updated

July 20, 2023

Status Verified

July 1, 2023

Enrollment Period

6 months

First QC Date

March 17, 2023

Last Update Submit

July 19, 2023

Conditions

Keywords

interdental papillamultilayer L-PRFHyaluronic acid gel

Outcome Measures

Primary Outcomes (1)

  • The gingival black triangle height

    to evaluate the influence of hyaluronic acid gel injection versus multilayer L-PRF on the height of black triangle

    six months

Secondary Outcomes (3)

  • Assessment pf patient satisfaction using Patient Satisfaction Questionnaire

    patients scores are evaluated at baseline immediately after the procedure

  • Post operative pain assessment using Numerical Pain Rating Scale

    six months

  • Assessment of esthetic appearance using the GAIS (global esthetic improvement scale)

    six months

Study Arms (2)

Hyaluronic acid gel

EXPERIMENTAL

will include 10 patients undergoing non invasive reconstruction of interdental papilla using injectable Hyaluronic acid gel

Combination Product: Hyaluronic acid gel

Multilayer L-PRF

ACTIVE COMPARATOR

will include 10 patients undergoing minimally invasive surgery for reconstruction of interdental papilla using multilayer L-PRF membranes

Combination Product: Multilayer L-PRF membranes

Interventions

Hyaluronic acid gelCOMBINATION_PRODUCT

For the Hyaluronic acid gel group: HA gel was injected 2-3mm apical to the coronal tip of the involved papillae and the needle was directed coronally with an angulation of 45° to the long axis of the tooth, and the bevel directed apically until papilla became blanched. The injection was given at each papilla at the following intervals baseline, one week and two weeks.

Also known as: HA gel
Hyaluronic acid gel
Multilayer L-PRF membranesCOMBINATION_PRODUCT

For the multilayer L-PRF group: A single semilunar incision is made in the buccal vestibule, apical to the muco-gingival junction in the mid interproximal area of the papilla to be treated.Tunneling of the incisions has maintained the full height and thickness of the gingiva. Multilayer L-PRF membranes were prepared according to Pinto's protocol immediately prior to the surgery and placed in the tunnel then incision was closed with simple interrupted sutures.

Multilayer L-PRF

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Both genders aged from 18-45 years.
  • Systemically healthy patients.
  • Patients with IDP loss class I or II of esthetic zone in upper and lower anterior and premolar teeth according to Nordland and Tarnow's classification (Class I: Presence of the tip of the papilla between interdental contact point and the interproximal CEJ)
  • Presence of sufficient interdental alveolar bone (i.e. the vertical distance from the interdental contact point to the crest of the interdental bone is ≥ 5 mm) that was confirmed clinically by bone sounding.
  • A band of keratinized tissue should be present around the test teeth ≥ 2 mm
  • Periodontal phenotype of the area to be treated is ≥ 2 mm in thickness. Surgical reconstruction of IDP is influenced by gingival tissue phenotype, outcome of papilla reconstruction is better in cases with a thick gingival unit
  • Patients with good oral hygiene and caring about esthetics and concerned to go through the management of "black triangles" by interdental papillae reconstruction in esthetic zone.

You may not qualify if:

  • Teeth with acute periapical pathosis.
  • Patients with poor oral hygiene, incompliance to treatment and persistence of gingival inflammation after phase I therapy.
  • Pregnant and lactating females.
  • Patients having para-functional habits or local causes as, malocclusion, interdental spacing, rotation, inclination or crowding.
  • Smokers, alcoholics or drug abusers.
  • Vulnerable group of patients, orphans, handicapped, prisoners or mentally retarded patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of Dentistry. Ain Shams University

Cairo, Egypt

Location

Study Officials

  • Aya Alleithy, teaching assistant

    Teaching assistant at Department of Oral medicine, Periodontology, and Oral Diagnosis, Faculty of Dentistry, A

    PRINCIPAL INVESTIGATOR
  • Hala Abu El-Ela, proffessor

    Professor of Oral Medicine, Periodontology and Oral Diagnosis , Faculty of Dentistry-Ain Shams University & Misr International university

    STUDY DIRECTOR
  • Susan Sarhan, lecturer

    Lecturer of Oral Medicine and Periodontology and Oral diagnosis, Faculty of Dentistry, Ain Shams University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: this study is designed as a parallel randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

March 17, 2023

First Posted

July 20, 2023

Study Start

January 10, 2022

Primary Completion

July 10, 2022

Study Completion

October 15, 2022

Last Updated

July 20, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations